Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

50 results about "Intraventricular Cardiac" patented technology

Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt

Pharmaceutical compositions are disclosed suitable for parenteral administration having anti-inflammatory, analgesic, and anti-pyretic properties, which consist of a therapeutically effective amount of d,l or l-lysine salt of R,S or S-ibuprofen as active ingredient dissolved in sterile water to form a solution in the absence of an inert atmosphere and either substantially free or absolutely free of any excipient, organic solvent, buffer, acid, base, salt other than the active ingredient and capable of storage in the absence of an inert atmosphere. Also disclosed are methods employing the new compositions in the treatment of pain and inflammation, in reducing fever and in treating patent ductus arterious or intraventricular hemorrhage in prematurely born neonates.
Owner:FARMACON IL

Left ventricle segmentation method and device and electronic equipment

The invention provides a left ventricle segmentation method and device and electronic equipment, and the method comprises the steps of obtaining cardiac medical image data; determining a cardiac apexposition and a cardiac base position in the medical image data according to the heart physiological structure characteristics; determining a left ventricular cavity segmentation result by adopting a region growing algorithm based on the cardiac apex position and the cardiac base position; according to the left ventricular cavity segmentation result, performing segmentation based on a level set algorithm to obtain a left myocardial segmentation result; and combining the left ventricular cavity segmentation result and the left myocardial segmentation result to obtain a left ventricular segmentation result. As the apex and the heart base are located in the ventricle, an accurate left ventricular cavity segmentation result can be obtained by adopting a region growing method based on the apex and the heart base, and due to the fact that the left ventricular cavity and the left myocardium are large in gray scale difference and obvious in gray scale gradient change, accurate left myocardium segmentation is conducted through a level set algorithm on the basis of the left ventricular cavity segmentation result, and the evolution speed is fast.
Owner:SAINUO WEISHENG SCI & TECH BEIJING

Cardiac apex mediated heart volume reduction implant

PendingCN107303206ATo achieve the effect of automatic height adjustmentImprove securityHeart valvesSurgeryHeart apexHeart volume
The invention discloses a cardiac apex mediated heart volume reduction implant which comprises a braid base, an umbrella-shaped frame on the braid base, and an isolating membrane on the umbrella-shaped frame, wherein the umbrella-shaped frame comprises supporting bars towards the upper part of the outer side; and the upper ends of the supporting bars are bent to form horizontal folds. The heart volume reduction implant aims at characteristics and needs of minimally invasive intervention treatment, particularly the contractility of the braid base is improved by optimizing the structure of the braid base and the structure of the umbrella-shaped frame, and the heart volume reduction implant is facilitated to be loaded into a delivery system, so that the diameter of delivery catheter can be reduced, and damage of endovascular tissues in the implantation process is reduced. Moreover, enough thickness of the braid base is ensured, the effect of automatically adjusting the height of the heart volume reduction implant can be achieved, and the supporting bars with horizontal folds are adopted in the implant, so that the implant is facilitated to be fully unfolded without being influenced by a ventricular space in the release process, and the implant can be firmly fixed on the premise of not damaging ventricular walls.
Owner:GUANGDONG PULSE MEDICAL SCI & TECH CO LTD

Pulse-adjustable TAVR operation simulator

The invention discloses a pulse-adjustable TAVR operation simulator which comprises a control box. An LCD display screen is arranged on the control box, the LCD display screen is connected with a control panel in the control box, an adjustable flow button, an adjustable frequency button and a power supply main switch are arranged on the control box, and the LCD display screen, the adjustable flow button and the adjustable frequency button are respectively connected with the 7V voltage power supply module, the 24V voltage power supply module and the UART interface end; the power main switch is connected with the main power supply module; the control panel is connected with a submersible pump which is connected with a simulated blood vessel pipeline in the water tank; when a frequency button of the LCD display screen is pressed down, the control panel sends a signal to the submersible pump, the submersible pump performs intermittent action, and when the submersible pump discharges water, the submersible pump penetrates through the aortic valve from the ventricle to reach the ascending aorta, the aortic valve is opened and the submersible pump sucks water, the pressure in the ventricle is reduced, the ascending aorta applies pressure to the aortic valve, and the aortic valve is closed; and a complete heart cycle is simulated. The simulator has the characteristics of high reliability, quick response, small size and easiness in assembly.
Owner:陕西马克医疗科技有限公司

Ventricular assist device and application method

The invention belongs to the technical field of medical instruments, and particularly relates to a ventricular assist device and an application method thereof. The ventricular assist device includes astand, a connecting line and an anchoring structure, wherein the stand includes a plurality of elastic support arms and an annular support, the rears of the elastic support arms are connected to theannular edge of the annular support so as to form a claw-shaped support structure which is adapted to the ventricular structure and applied to radial support of the inner wall of the ventricle, and the anchoring structure is anchored in the ventricle; the annular support is connected with the anchoring structure through the connecting line so as to fix the stand in the ventricle, the outer sides of the elastic support arms are in contact with the inner wall of the ventricle, and the elastic support arms are compressed by force when the ventricle contracts, and restores and expands when ventricular diastole occurs. The ventricular assist device can be compressed during ventricular contraction, so that energy is stored, and a radial support force is generated; ventricular diastole is assisted through the radial support force during ventricular diastole, so that heart functions are improved; and the ventricular assist device has a simple structure and high compatibility.
Owner:QICHEN (SHANGHAI) MEDICAL EQUIP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products